Growth and scale Curallux is a mid-sized US manufacturer with 11-50 employees and a revenue range of $25M-$50M, indicating established operations and potential capacity for expanded sales of photobiomodulation devices to new clinics, hospitals, and wellness facilities.

Clinical credibility ISO-13485 certification and FDA-cleared Capillus laser devices provide strong regulatory credibility and clinician trust, creating opportunities to partner with dermatology, trichology, and pain management practices seeking proven, non-pharmaceutical treatment options.

Diversified offerings Product lines span hair restoration (Capillus) and pain management (Curavi), suggesting cross-sell potential to existing customers and the ability to address multiple patient segments within wellness, aesthetics, and rehabilitation markets.

E-commerce and B2B readiness Tech stack includes WordPress, Shopify, WooCommerce, and Zendesk, signaling strong digital sales capability and potential for direct online purchases as well as channel partnerships with clinics and distributors.

Growth opportunities With a presence in professional medical devices and a growing field in non-pharmaceutical pain solutions, there is scope to expand into adjacent markets such as physical therapy, sports medicine, and vanity/aesthetic clinics, leveraging proven clinical outcomes to drive inquiries and trials.